These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


79 related items for PubMed ID: 8512702

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sphere-linked immunodiagnostic assay (SLIDA): an electron microscopic method for detecting specific antibodies.
    Hari V, Baunoch D, Das P.
    Biotechniques; 1990 Sep; 9(3):342-50. PubMed ID: 2223076
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 9. A serological screening assay of human immunodeficiency virus type 1 antibodies based on recombinant protein p24-gp41 as a fusion protein expressed in Escherichia coli.
    Mahboudi F, Irina NA, Chevalier A, Ghadiri A, Adeli A, Amini-Bavil-Olyaee S, Barkhordari F, Farzamfar B, Alinejad M.
    J Biotechnol; 2006 Sep 01; 125(2):295-303. PubMed ID: 16647775
    [Abstract] [Full Text] [Related]

  • 10. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J, Salvetti JL, Beltramini LM, Tonarelli G.
    Rev Argent Microbiol; 2004 Sep 01; 36(4):151-7. PubMed ID: 15786866
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of a new fourth-generation microwell enzyme-linked immunosorbent assay for detection of HIV-1 subtype B and E antibodies.
    Chanbancherd P, Limpairojn N, de Souza MS, Jugsudee A, Julananto P, Tienamporn P, Leucha W, Tasaniyananda C, Brown AE.
    Southeast Asian J Trop Med Public Health; 2001 Mar 01; 32(1):177-9. PubMed ID: 11485082
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D.
    J Hum Virol; 2001 Mar 01; 4(6):306-16. PubMed ID: 12082397
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Expression and characterization of HIV-1 Gag p17-p24 protein].
    Li TY, Jin NY, Wang HW, Guo ZR, Fang HH, An RG, Yin Z.
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan 01; 16(1):65-8. PubMed ID: 10883279
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multiplex analysis of heterophil antibodies in patients with indeterminate HIV immunoassay results.
    Willman JH, Hill HR, Martins TB, Jaskowski TD, Ashwood ER, Litwin CM.
    Am J Clin Pathol; 2001 May 01; 115(5):764-9. PubMed ID: 11345842
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The detection of antibodies against HIV-1 24-kd protein. A clinico-serological correlation].
    Díaz Torres H, Silva Cabrera E, Rodríguez García O, Bárcenas Moses J, Lubián Caballero AL.
    Rev Cubana Med Trop; 1996 May 01; 48(3):188-91. PubMed ID: 9805049
    [Abstract] [Full Text] [Related]

  • 20. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities.
    Tobin GJ, Li GH, Fong SE, Nagashima K, Gonda MA.
    Virology; 1997 Sep 29; 236(2):307-15. PubMed ID: 9325238
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.